A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.

Malaviya, A N; Kapoor, S; Garg, S; Ahmad, I; Raja, R R

Malaviya, A N; Kapoor, S; Garg, S; Ahmad, I; Raja, R R.

Article in En | IMSEAR | ID: sea-93001

Subject(s)

Adolescent; Adult; Antirheumatic Agents/therapeutic use; Bone Density Conservation Agents/therapeutic use; Diphosphonates/therapeutic use; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids/therapeutic use; Humans; Infusions, Intravenous; Male; Methotrexate/therapeutic use; Methylprednisolone/therapeutic use; Middle Aged; Spondylitis, Ankylosing/drug therapy; Sulfasalazine/therapeutic use

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Sulfasalazine / Spondylitis, Ankylosing / Infusions, Intravenous / Female / Humans / Male / Drug Resistance / Methylprednisolone / Methotrexate / Adolescent Language: En Year: 2007 Type: Article

Fulltext

Add to My VHL

XML

Search on Google